Starling Oncology, Inc. Cash and Restricted Cash
Starling Oncology, Inc. (STLN) had Cash and Restricted Cash of $41.09 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $41.09M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30.28M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33.56M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.66M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $41.09M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $30.28M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $33.56M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $27.66M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $30.29M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $39.74M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $49.67M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $47.40M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $36.42M 10-Q · filed 2025-08-13 | |
| 2024-03-31 | $36.05M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $33.49M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $27.54M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $28.89M 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $15.25M 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $14.01M 10-K · filed 2025-03-26 | |
| 2022-09-30 | $61.42M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $64.21M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $95.53M 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $115.17M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $11.53M 10-Q · filed 2022-11-09 | $204.87K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $15.17M 10-Q · filed 2022-08-09 | $620.73K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $27.41M 10-Q · filed 2022-05-10 | $573.33K 10-Q · filed 2021-05-28 |
| 2020-12-31 | $6.00M 10-K · filed 2023-03-16 | $916.99K 10-K · filed 2021-03-30 |
| 2020-09-30 | $998.57K 10-Q/A · filed 2021-12-14 | |
| 2020-06-30 | $1.10M 10-Q · filed 2021-08-16 | |
| 2020-03-31 | $1.51M 10-Q · filed 2021-05-28 | |
| 2019-12-31 | $2.45M 10-K · filed 2022-03-11 | $25.00K 10-Q · filed 2020-05-08 |
| 2019-10-31 | $0.00 10-K/A · filed 2021-12-14 |